Nasal Cavity

Download PDF

Recent Publications on Nasal Cavity:
DCEMRI monitoring of canine tumors during fractionated radiotherapy. Purpose. To monitor the contrast enhancement in spontaneous canine tumors...	12th July, 2008	Department of Radiation Biology, Institute for Cancer Research,	Acta Oncol. 2008 Jul 11;:1-8. DOI Direct Link
Comparative gene expression profiling of olfactory ensheathing glia and Schwann cells indicates distinct tissue repair characteristics of olfactory ensheathing glia. Olfactory ensheathing glia (OEG) are a specialized type of glia that...	11th July, 2008	Netherlands Insitute for Neuroscience, An Institute of the Royal	Glia. 2008 Jul 9;. DOI Direct Link
How to prevent immunological reactions in leprosy patients and interrupt transmission of Mycobacterium leprae to healthy subjects: Two hypotheses. The basis of World Health Organization strategy for leprosy elimination is...	11th July, 2008	Department of Environmental Medicine and Public Health, Padova University	Med Hypotheses. 2008 Jul 7;. DOI Direct Link
Canine sino-nasal aspergillosis: parallels with human disease. Canine sino-nasal aspergillosis (SNA) is characterized by the formation of...	9th July, 2008	Division of Veterinary Pathology, Infection and Immunity, School of	Med Mycol. 2008 Jun 26;:1-9. DOI Direct Link
Endoscopic surgery for inverted papilloma originating from the sphenoid sinus and related clinical characteristics. Conclusions. Bony changes on CT imaging of inverted papilloma (IP) are...	9th July, 2008	Department of Otorhinolaryngology, Yonsei University College of Medicine,	Acta Otolaryngol. 2008 Mar 14;:1-6. DOI Direct Link
→View more research publications.

Nasal Cavity Clinical Trials:
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison	Chronic Sinusitis
Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer	Head and Neck Cancer
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor	Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gastric Cancer;   Head and Neck Cancer;   Liver Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
NGR-TNF in Treating Patients With Advanced Solid Tumors	Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors	Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Pancreatic Cancer;   Prostate Cancer;   Sarcoma
→View more trials.

Nasal Cavity Patents:
US Patent No.	Title
7351253	Intranasal red light probe for treating Alzheimer's disease
7364267	Liquid ejection head
7365063	Quinazolinone and benzoxazinone derivatives and uses thereof
7365067	Indanol derivative
7365085	Compounds and methods
→View more patents.

Companies working in the area of Nasal Cavity from Bioportfolio's Biocorporate database :
Company Name
Matrixx Initiatives Matrixx Initiatives, Inc. (Nasdaq: MTXX) is changing the way consumers use healthcare products. Matrixx is a high growth over-the-counter healthcare company engaged in the development and marketing of... www.matrixxinc.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Nasal Cavity scientists - we have details of around 1016 individuals working on Nasal Cavity .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.